HK-II expression is increased in many malignant tumors, including nasopharyngeal cancer, ovarian cancer, renal cell carcinoma, hepatocellular carcinoma, colon cancer, and glioma20. This evidence concerns the gene HK2 and hereditary clear cell renal cell carcinoma.